Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Abortion Drugs

Abortion Drugs

83 results

Filter Results By

Filter Applied. Clear All
Reset All Filters
83 results
Abortion Drugs

Fact Sheet: Questions and Answers on Born-Alive Abortion Survivors

This fact sheet unpacks the reality of born-alive abortion survivors in the United States.

charlotte-lozier-institute Charlotte Lozier Institute
December 19, 2024
Please login to bookmark Close
featured-image
Abortion Drugs

Fact Sheet: A Summary of the CDCā€™s 2022 Abortion Surveillance Report

The CDC released its annual abortion surveillance report on November 28, detailing 2022 abortion data in 48 reporting areas (46 states, NYC, and D.C.). Included in this fact sheet are key data points from that report.

Abortion Drugs

Abortion Reporting: Massachusetts (2023)

Abortions in Massachusetts significantly increased from 2022 to 2023.

featured-image
Abortion Drugs

ADF, Consovoy McCarthy sue academic publisher for politically motivated retractions

Attorneys representing 10 scientists ask California court to compel Sage Publications to stick to its contractual obligation, pursue arbitration.

featured-image
Abortion Drugs

New Study Reveals Increasing Severity and Frequency of Emergency Department Visits Following Use of Abortion Drugs

A new study published in the International Journal of Epidemiology and Public Health Research by Dr. James Studnicki, Dr. Ingrid Skop, Tessa Cox, and other CLI scholars, reveals the increasing severity and frequency of emergency department visits among Medicaid-eligible women from 17 states where Medicaid pays for abortion following different pregnancy outcomes.

Abortion Drugs

Study finds 75% of women treated at ERs after taking abortion pills rated ā€˜severe or criticalā€™

Women who visit emergency rooms after taking abortion pills are more likely to be seen for serious medical problems than their cohorts whose pregnancies end with surgical abortions or live births, according to newly released research.

Abortion Drugs

Primer: The Basic Biochemistry of Abortion Pill Reversal

This primer lays out the science behind Abortion Pill Reversal by examining the function of progesterone as a naturally occurring hormone in the female reproductive system, the functions of mifepristone and misoprostol as drugs used in drug-induced abortion, the basic biochemical principle of competitive inhibition, and the disinformation surrounding the role of progesterone in reversing the abortion drug.

featured-image
Abortion Drugs

United Kingdom Data Deficiencies Influencing U.S. FDA Decisions

CLI's VP of Medical Affairs Ingrid Skop, together with Calum Miller, MD, and Kevin Duffy, MPH, recently published an article in Issues in Law & Medicine arguing that decisions by the FDA to pull back regulations on the abortion drug mifepristone in part relied on "flawed studies with significantly undercounted complications" from the U.K.

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image